The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail vetinfo@hpra.ie


Nobivac DHPPi

. Lyophilisate for solution for injection

Intervet Ireland LimitedVPA10996/166/001

Main Information

Trade NameNobivac DHPPi
Active SubstancesCanine distemper virus strain ondertespoort (live)
Canine adenovirus type 2 strain manhattan lpv3 (live)
Canine parvovirus strain 154 (live)
Canine parainfluenza virus strain Cornell (Live)
Strength.
Dosage FormLyophilisate for solution for injection
Licence HolderIntervet Ireland Limited
Licence NumberVPA10996/166/001

Group Information

ATC CodeQI07AD04 canine distemper virus + canine adenovirus + canine parvovirus + canine parainfluenza virus
Therapeutic ClassImmunological - Live Vaccine
SpeciesDogs

Status

Authorised/WithdrawnAuthorised
Licence Issued03/06/2005
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back